Protein arginine methyltransferases (PRMTs): Role in chromatin organization

Advances in Biological Regulation

Volumn 57, Issue , 2015, Pages 173-184

  Jahan, Sanzida ^a   Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chromatin organization; Epigenetics; Histone modifications; Protein arginine methyltransferases

Indexed keywords

MAMMALIA;

CHROMATIN; PROTEIN ARGININE METHYLTRANSFERASE; TUMOR PROTEIN;

ANIMAL; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN PROCESSING;

ANIMALS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-ARGININE N-METHYLTRANSFERASES;

EID: 84920819082     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2014.09.003     Document Type: Review

References (132)

1. Alevy M.C., Tsai M.J., O'Malley B.W. DNase I sensitive domain of the gene coding for the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 1984, 23:2309-2314.
2. An W., Kim J., Roeder R.G. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 2004, 117:735-748.
3. Andrade M.A., Perez-Iratxeta C., Ponting C.P. Protein repeats: structures, functions, and evolution. JStruct Biol 2001, 134:117-131.
4. Antes T.J., Namciu S.J., Fournier R.E., Levy-Wilson B. The 5' boundary of the human apolipoprotein B chromatin domain in intestinal cells. Biochemistry 2001, 40:6731-6742.
5. Aravind L., Abhiman S., Iyer L.M. Natural history of the eukaryotic chromatin protein methylation system. Prog Mol Biol Trans Sci 2011, 101:105-176.
6. Baldwin R.M., Morettin A., Cote J. Role of PRMTs in cancer: could minor isoforms be leaving a mark?. World J Biol Chem 2014, 5:115-129.
7. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
8. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., Kouzarides T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep 2002, 3:39-44.
9. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009, 33:1-13.
10. Bedford M.T., Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 2005, 18:263-272.
11. Bezzi M., Teo S.X., Muller J., Mok W.C., Sahu S.K., Vardy L.A., et al. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery. Genes Dev 2013, 27:1903-1916.
12. Bickmore W.A., van Steensel B. Genome architecture: domain organization of interphase chromosomes. Cell 2013, 152:1270-1284.
13. Bleibel W.K., Duan S., Huang R.S., Kistner E.O., Shukla S.J., Wu X., et al. Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum Genet 2009, 125:173-180.
14. Blythe S.A., Cha S.W., Tadjuidje E., Heasman J., Klein P.S. beta-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2. Dev Cell 2010, 19:220-231.
15. Boisvert F.M., Chenard C.A., Richard S. Protein interfaces in signaling regulated by arginine methylation. Sci STKE 2005, 2005:re2.
16. Buhr N., Carapito C., Schaeffer C., Kieffer E., Van Dorsselaer A., Viville S. Nuclear proteome analysis of undifferentiated mouse embryonic stem and germ cells. Electrophoresis 2008, 29:2381-2390.
17. Casadio F., Lu X., Pollock S.B., LeRoy G., Garcia B.A., Muir T.W., et al. H3R42me2a is a histone modification with positive transcriptional effects. Proc Natl Acad Sci U S A 2013, 110:14894-14899.
18. Cesaro E., De Cegli R., Medugno L., Florio F., Grosso M., Lupo A., et al. The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene. JBiol Chem 2009, 284:32321-32330.
19. Cha B., Jho E.H. Protein arginine methyltransferases (PRMTs) as therapeutic targets. Expert Opin Ther Targets 2012, 16:651-664.
20. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., et al. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
21. Cheng X., Collins R.E., Zhang X. Structural and sequence motifs of protein (histone) methylation enzymes. Annu Rev Biophys Biomol Struct 2005, 34:267-294.
22. Cheung N., Chan L.C., Thompson A., Cleary M.L., So C.W. Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol 2007, 9:1208-1215.
23. Chung J., Karkhanis V., Tae S., Yan F., Smith P., Ayers L.W., et al. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing. JBiol Chem 2013, 288:35,534-35,547.
24. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., et al. Histone deimination antagonizes arginine methylation. Cell 2004, 118:545-553.
25. Dacwag C.S., Ohkawa Y., Pal S., Sif S., Imbalzano A.N. The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling. Mol Cell Biol 2007, 27:384-394.
26. Daujat S., Bauer U.M., Shah V., Turner B., Berger S., Kouzarides T. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol: CB 2002, 12:2090-2097.
27. Denis H., Deplus R., Putmans P., Yamada M., Metivier R., Fuks F. Functional connection between deimination and deacetylation of histones. Mol Cell Biol 2009, 29:4982-4993.
28. Di Lorenzo A., Bedford M.T. Histone arginine methylation. FEBS Lett 2011, 585:2024-2031.
29. Di Lorenzo A., Yang Y., Macaluso M., Bedford M.T. Again-of-function mouse model identifies PRMT6 as a NF-kappaB coactivator. Nucleic Acids Res 2014, 42:8297-8309.
30. Dixon J.R., Selvaraj S., Yue F., Kim A., Li Y., Shen Y., et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012, 485:376-380.
31. El Messaoudi S., Fabbrizio E., Rodriguez C., Chuchana P., Fauquier L., Cheng D., et al. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc Natl Acad Sci U S A 2006, 103:13351-13356.
32. Follo M.Y., Marmiroli S., Faenza I., Fiume R., Ramazzotti G., Martelli A.M., et al. Nuclear phospholipase C beta1 signaling, epigenetics and treatments in MDS. Adv Biol Regul 2013, 53:2-7.
33. Furlan-Magaril M., Rebollar E., Guerrero G., Fernandez A., Molto E., Gonzalez-Buendia E., et al. An insulator embedded in the chicken alpha-globin locus regulates chromatin domain configuration and differential gene expression. Nucleic Acids Res 2011, 39:89-103.
34. Gallagher P.G., Nilson D.G., Steiner L.A., Maksimova Y.D., Lin J.Y., Bodine D.M. An insulator with barrier-element activity promotes alpha-spectrin gene expression in erythroid cells. Blood 2009, 113:1547-1554.
35. Gallagher P.G., Steiner L.A., Liem R.I., Owen A.N., Cline A.P., Seidel N.E., et al. Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis. JClin Invest 2010, 120:4453-4465.
36. Ganesh L., Yoshimoto T., Moorthy N.C., Akahata W., Boehm M., Nabel E.G., et al. Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. Mol Cell Biol 2006, 26:3864-3874.
37. Gardner K.E., Allis C.D., Strahl B.D. Operating on chromatin, a colorful language where context matters. JMol Biol 2011, 409:36-46.
38. Gayatri S., Bedford M.T. Readers of histone methylarginine marks. Biochim Biophys Acta 2014, 1839:702-710.
39. Ghirlando R., Giles K., Gowher H., Xiao T., Xu Z., Yao H., et al. Chromatin domains, insulators, and the regulation of gene expression. Biochim Biophys Acta 2012, 1819:644-651.
40. Girardot M., Hirasawa R., Kacem S., Fritsch L., Pontis J., Kota S.K., et al. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G+C-rich regions of the mouse genome. Nucleic Acids Res 2014, 42:235-248.
41. Gonsalvez G.B., Tian L., Ospina J.K., Boisvert F.M., Lamond A.I., Matera A.G. Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins. JCell Biol 2007, 178:733-740.
42. Gros L., Delaporte C., Frey S., Decesse J., de Saint-Vincent B.R., Cavarec L., et al. Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents. Cancer Res 2003, 63:164-171.
43. Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M., Schuchlautz H., et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007, 449:933-937.
44. Guccione E., Martinato F., Finocchiaro G., Luzi L., Tizzoni L., Dall' Olio V., et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 2006, 8:764-770.
45. Hardisty-Hughes R.E., Tateossian H., Morse S.A., Romero M.R., Middleton A., Tymowska-Lalanne Z., et al. Amutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. Hum Mol Genet 2006, 15:3273-3279.
46. Hebbes T.R., Clayton A.L., Thorne A.W., Crane-Robinson C. Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J 1994, 13:1823-1830.
47. Hou Z., Peng H., Ayyanathan K., Yan K.P., Langer E.M., Longmore G.D., et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 2008, 28:3198-3207.
48. Huang S., Litt M., Felsenfeld G. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential invivo for many subsequent histone modifications. Genes Dev 2005, 19:1885-1893.
49. Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., et al. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 2007, 21:3369-3380.
50. Iberg A.N., Espejo A., Cheng D., Kim D., Michaud-Levesque J., Richard S., et al. Arginine methylation of the histone H3 tail impedes effector binding. JBiol Chem 2008, 283:3006-3010.
51. Ito T., Yadav N., Lee J., Furumatsu T., Yamashita S., Yoshida K., et al. Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification. BMC Dev Biol 2009, 9:47.
52. Jelinic P., Stehle J.C., Shaw P. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol 2006, 4:e355.
53. Karkhanis V., Hu Y.J., Baiocchi R.A., Imbalzano A.N., Sif S. Versatility of PRMT5-induced methylation in growth control and development. Trends Biochem Sci 2011, 36:633-641.
54. Kim J., Lee J., Yadav N., Wu Q., Carter C., Richard S., et al. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. JBiol Chem 2004, 279:25,339-25,344.
55. Kim Y.R., Lee B.K., Park R.Y., Nguyen N.T., Bae J.A., Kwon D.D., et al. Differential CARM1 expression in prostate and colorectal cancers. BMC Cancer 2010, 10:197.
56. Kleinschmidt M.A., Streubel G., Samans B., Krause M., Bauer U.M. The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation. Nucleic Acids Res 2008, 36:3202-3213.
57. Kooistra S.M., Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012, 13:297-311.
58. Krause C.D., Yang Z.H., Kim Y.S., Lee J.H., Cook J.R., Pestka S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther 2007, 113:50-87.
59. Kuhn P., Xu W. Protein arginine methyltransferases: nuclear receptor coregulators and beyond. Prog Mol Biol Trans Sci 2009, 87:299-342.
60. Lacroix M., El Messaoudi S., Rodier G., Le Cam A., Sardet C., Fabbrizio E. The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep 2008, 9:452-458.
61. Lakowski T.M., Frankel A. Akinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism. JBiol Chem 2008, 283:10015-10025.
62. Lawson G.M., Knoll B.J., March C.J., Woo S.L., Tsai M.J., O'Malley B.W. Definition of 5' and 3' structural boundaries of the chromatin domain containing the ovalbumin multigene family. JBiol Chem 1982, 257:1501-1507.
63. Le Guezennec X., Vermeulen M., Brinkman A.B., Hoeijmakers W.A., Cohen A., Lasonder E., et al. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 2006, 26:843-851.
64. Lee J., Bedford M.T. PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. EMBO Rep 2002, 3:268-273.
65. Lee J., Sayegh J., Daniel J., Clarke S., Bedford M.T. PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family. JBiol Chem 2005, 280:32,890-32,896.
66. Lee J.H., Cook J.R., Yang Z.H., Mirochnitchenko O., Gunderson S.I., Felix A.M., et al. PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine. JBiol Chem 2005, 280:3656-3664.
67. Li X., Wang S., Li Y., Deng C., Steiner L.A., Xiao H., et al. Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood 2011, 118:1386-1394.
68. Lin W.J., Gary J.D., Yang M.C., Clarke S., Herschman H.R. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. JBiol Chem 1996, 271:15034-15044.
69. Liu W., Ma Q., Wong K., Li W., Ohgi K., Zhang J., et al. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell 2013, 155:1581-1595.
70. Lupien M., Eeckhoute J., Meyer C.A., Krum S.A., Rhodes D.R., Liu X.S., et al. Coactivator function defines the active estrogen receptor alpha cistrome. Mol Cell Biol 2009, 29:3413-3423.
71. Ma M.K., Heath C., Hair A., West A.G. Histone crosstalk directed by H2B ubiquitination is required for chromatin boundary integrity. PLoS Genet 2011, 7:e1002175.
72. Majumder S., Liu Y., Ford O.H., Mohler J.L., Whang Y.E. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 2006, 66:1292-1301.
73. Margueron R., Justin N., Ohno K., Sharpe M.L., Son J., Drury W.J., et al. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 2009, 461:762-767.
74. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
75. Migliori V., Muller J., Phalke S., Low D., Bezzi M., Mok W.C., et al. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat Struct Mol Biol 2012, 19:136-144.
76. Migliori V., Phalke S., Bezzi M., Guccione E. Arginine/lysine-methyl/methyl switches: biochemical role of histone arginine methylation in transcriptional regulation. Epigenomics 2010, 2:119-137.
77. Molina-Serrano D., Schiza V., Kirmizis A. Cross-talk among epigenetic modifications: lessons from histone arginine methylation. Biochem Soc Trans 2013, 41:751-759.
78. Neuenkirchen N., Chari A., Fischer U. Deciphering the assembly pathway of Sm-class U snRNPs. FEBS Lett 2008, 582:1997-2003.
79. O'Brien K.B., Alberich-Jorda M., Yadav N., Kocher O., Diruscio A., Ebralidze A., et al. CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development 2010, 137:2147-2156.
80. Ou C.Y., LaBonte M.J., Manegold P.C., So A.Y., Ianculescu I., Gerke D.S., et al. Acoactivator role of CARM1 in the dysregulation of beta-catenin activity in colorectal cancer cell growth and gene expression. Mol Cancer Res 2011, 9:660-670.
81. Pahlich S., Zakaryan R.P., Gehring H. Protein arginine methylation: cellular functions and methods of analysis. Biochim Biophys Acta 2006, 1764:1890-1903.
82. Pal S., Sif S. Interplay between chromatin remodelers and protein arginine methyltransferases. JCell Physiol 2007, 213:306-315.
83. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004, 24:9630-9645.
84. Pesavento J.J., Bullock C.R., LeDuc R.D., Mizzen C.A., Kelleher N.L. Combinatorial modification of human histone H4 quantitated by two-dimensional liquid chromatography coupled with top down mass spectrometry. JBiol Chem 2008, 283:14927-14937.
85. Phanstiel D., Brumbaugh J., Berggren W.T., Conard K., Feng X., Levenstein M.E., et al. Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc Natl Acad Sci U S A 2008, 105:4093-4098.
86. Pollack B.P., Kotenko S.V., He W., Izotova L.S., Barnoski B.L., Pestka S. The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. JBiol Chem 1999, 274:31531-31542.
87. Rank G., Cerruti L., Simpson R.J., Moritz R.L., Jane S.M., Zhao Q. Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression. Blood 2010, 116:1585-1592.
88. Rathert P., Dhayalan A., Murakami M., Zhang X., Tamas R., Jurkowska R., et al. Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol 2008, 4:344-346.
89. Recillas-Targa F., Razin S.V. Chromatin domains and regulation of gene expression: familiar and enigmatic clusters of chicken globin genes. Crit Rev Eukaryot Gene Expr 2001, 11:227-242.
90. Robin-Lespinasse Y., Sentis S., Kolytcheff C., Rostan M.C., Corbo L., Le Romancer M. hCAF1, a new regulator of PRMT1-dependent arginine methylation. JCell Sci 2007, 120:638-647.
91. Rosenfeld J.A., Wang Z., Schones D.E., Zhao K., DeSalle R., Zhang M.Q. Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 2009, 10:143.
92. Sakabe K., Hart G.W. O-GlcNAc transferase regulates mitotic chromatin dynamics. JBiol Chem 2010, 285:34460-34468.
93. Sayegh J., Webb K., Cheng D., Bedford M.T., Clarke S.G. Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain. JBiol Chem 2007, 282:36,444-36,453.
94. Scaramuzzino C., Monaghan J., Milioto C., Lanson N.A., Maltare A., Aggarwal T., et al. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity invitro and invivo. PloS One 2013, 8:e61576.
95. Schurter B.T., Koh S.S., Chen D., Bunick G.J., Harp J.M., Hanson B.L., et al. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 2001, 40:5747-5756.
96. Selvi B.R., Batta K., Kishore A.H., Mantelingu K., Varier R.A., Balasubramanyam K., et al. Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. JBiol Chem 2010, 285:7143-7152.
97. Singh V., Miranda T.B., Jiang W., Frankel A., Roemer M.E., Robb V.A., et al. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates invitro and invivo. Oncogene 2004, 23:7761-7771.
98. Stein C., Riedl S., Ruthnick D., Notzold R.R., Bauer U.M. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes. Nucleic Acids Res 2012, 40:9522-9533.
99. Su X., Zhu G., Ding X., Lee S.Y., Dou Y., Zhu B., et al. Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1. Genes Dev 2014, 28:622-636.
100. Sugai M., Ohta A., Ogata Y., Nakanishi M., Ueno S., Kawata T., et al. Asymmetric dimethylarginine (ADMA) in the aqueous humor of diabetic patients. Endocr J 2007, 54:303-309.
101. Swiercz R., Cheng D., Kim D., Bedford M.T. Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. JBiol Chem 2007, 282:16,917-16,923.
102. Tabata T., Kokura K., Ten Dijke P., Ishii S. Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells 2009, 14:17-28.
103. Tae S., Karkhanis V., Velasco K., Yaneva M., Erdjument-Bromage H., Tempst P., et al. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes. Nucleic Acids Res 2011, 39:5424-5438.
104. Tang J., Gary J.D., Clarke S., Herschman H.R. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. JBiol Chem 1998, 273:16,935-16,945.
105. Turner B.M. Nucleosome signalling; an evolving concept. Biochim Biophys Acta 2014, 1839:623-626.
106. Valkonen V.P., Tuomainen T.P., Laaksonen R. DDAH gene and cardiovascular risk. Vasc Med 2005, 10(Suppl. 1):S45-S48.
107. Van Rechem C., Whetstine J.R. Examining the impact of gene variants on histone lysine methylation. Biochm Biophys Acta 2014.
108. Waldmann T., Izzo A., Kamieniarz K., Richter F., Vogler C., Sarg B., et al. Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenetics Chromatin 2011, 4:11.
109. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857.
110. Wang J., Chen L., Sinha S.H., Liang Z., Chai H., Muniyan S., et al. Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation. JMed Chem 2012, 55:7978-7987.
111. Wang L., Pal S., Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol 2008, 28:6262-6277.
112. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004, 306:279-283.
113. Wei H., Mundade R., Lange K.C., Lu T. Protein arginine methylation of non-histone proteins and its role in diseases. Cell Cycle 2014, 13:32-41.
114. Wei T.Y., Juan C.C., Hisa J.Y., Su L.J., Lee Y.C., Chou H.Y., et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade. Cancer Sci 2012, 103:1640-1650.
115. Weintraub H., Groudine M. Chromosomal subunits in active genes have an altered conformation. Science 1976, 193:848-856.
116. Wolf S.S. The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans. Cell Mol Life Sci 2009, 66:2109-2121.
117. Wu J., Cui N., Wang R., Li J., Wong J. Arole for CARM1-mediated histone H3 arginine methylation in protecting histone acetylation by releasing corepressors from chromatin. PloS One 2012, 7:e34692.
118. Xie Y., Ke S., Ouyang N., He J., Xie W., Bedford M.T., et al. Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1. JBiol Chem 2009, 284:9199-9205.
119. Yadav N., Lee J., Kim J., Shen J., Hu M.C., Aldaz C.M., et al. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc Natl Acad Sci U S A 2003, 100:6464-6468.
120. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. NEngl J Med 2006, 354:270-282.
121. Yang Y., Bedford M.T. Protein arginine methyltransferases and cancer. Nat Rev Cancer 2013, 13:37-50.
122. Yang Y., Lu Y., Espejo A., Wu J., Xu W., Liang S., et al. TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell 2010, 40:1016-1023.
123. Yao H., Brick K., Evrard Y., Xiao T., Camerini-Otero R.D., Felsenfeld G. Mediation of CTCF transcriptional insulation by DEAD-box RNA-binding protein p68 and steroid receptor RNA activator SRA. Genes Dev 2010, 24:2543-2555.
124. Yoshimatsu M., Toyokawa G., Hayami S., Unoki M., Tsunoda T., Field H.I., et al. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer 2011, 128:562-573.
125. Yuan C.C., Matthews A.G., Jin Y., Chen C.F., Chapman B.A., Ohsumi T.K., et al. Histone H3R2 symmetric dimethylation and histone H3K4 trimethylation are tightly correlated in eukaryotic genomes. Cell Rep 2012, 1:83-90.
126. Yue W.W., Hassler M., Roe S.M., Thompson-Vale V., Pearl L.H. Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase. EMBO J 2007, 26:4402-4412.
127. Zhang X., Cheng X. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 2003, 11:509-520.
128. Zhao Q., Rank G., Tan Y.T., Li H., Moritz R.L., Simpson R.J., et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat Struct Mol Biol 2009, 16:304-311.
129. Zhao X., Jankovic V., Gural A., Huang G., Pardanani A., Menendez S., et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 2008, 22:640-653.
130. Zheng Z., Schmidt-Ott K.M., Chua S., Foster K.A., Frankel R.Z., Pavlidis P., et al. AMendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci U S A 2005, 102:2502-2507.
131. Zhou Z., Sun X., Zou Z., Sun L., Zhang T., Guo S., et al. PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130. Cell Res 2010, 20:1023-1033.
132. Zurita-Lopez C.I., Sandberg T., Kelly R., Clarke S.G. Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming omega-NG-monomethylated arginine residues. JBiol Chem 2012, 287:7859-7870.